tralokinumab

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
02420102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
RATIONALE IL-13 is a potential therapeutic target for idiopathic pulmonary fibrosis (IPF); preclinical data suggest a role in… (More)
Is this relevant?
2017
2017
Interleukin (IL)-13 is a pleiotropic T helper type 2 cytokine frequently associated with asthma and atopic dermatitis. IL-13… (More)
Is this relevant?
2017
2017
OBJECTIVE Tralokinumab, administered as two 1-mL subcutaneous injections every 2 weeks, at the target dose 300 mg, has been shown… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2017
2017
Tralokinumab is a human monoclonal antibody in clinical development for asthma and atopic dermatitis that specifically… (More)
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Interleukin 13 is a central mediator of asthma. Tralokinumab is a human interleukin-13 neutralising monoclonal… (More)
Is this relevant?
2015
2015
OBJECTIVE Interleukin-13 (IL-13) has been implicated as a key driver of UC. This trial evaluates the efficacy and safety of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2015
2015
AIMS Tralokinumab, an investigational human immunoglobulin G4 monoclonal antibody, potently and specifically neutralizes… (More)
  • figure 1
  • figure 2
  • table 2
  • figure 4
  • figure 3
Is this relevant?
2015
2015
Contrary to a decade ago, clinical development in ulcerative colitis (UC) has become highly active with multiple promising… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Pre-clinical data demonstrate a pivotal role for interleukin (IL)-13 in the development and maintenance of asthma. This study… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
Biopharmaceutical approaches have been used to target key elements in the processes controlling airway inflammation in asthma and… (More)
Is this relevant?